ELAVL4 and amyotrophic lateral sclerosis: Silencing miR-129-5p expression using a locked nucleic acid oligonucleotide inhibitor led to increased expression of Hud, and inhibition of miRNA-129-5p in the ALS SOD1G93A mouse model improved the disease phenotype.45